AAAAAA

   
Results: 1-14 |
Results: 14

Authors: WOODWARD DF CHEN J KRAUSS AHP FAIRBAIRN CE PROTZMAN CE GAC T BURK RM CHAN MF
Citation: Df. Woodward et al., NEUTRAL REPLACEMENT OF THE CARBOXYLIC-ACID GROUP OF PROSTAGLANDIN-F2-ALPHA (PGF(2-ALPHA)) PROVIDES COMPOUNDS POSSESSING ACTIVITY CONSISTENTWITH FP RECEPTOR HETEROGENEITY, The FASEB journal, 12(4), 1998, pp. 875-875

Authors: CHEN J WOODWARD DF FAIRBAIRN CE KRAUSS AHP LAWRENCE RA PROTZMAN CE BURK RM MARSHALL K SENIOR J
Citation: J. Chen et al., REPLACEMENT OF THE CARBOXYLIC-ACID GROUP OF PROSTAGLANDIN-F2-ALPHA (PGF(2-ALPHA)) WITH NEUTRAL SUBSTITUENTS PROVIDES COMPOUNDS WITH UNIQUE PHARMACOLOGY, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 1733-1733

Authors: KRAUSS AHP WOODWARD DF BURK RM GAC TS GIBSON LL PROTZMAN CE ABBASS F MARSHALL K SENIOR J
Citation: Ahp. Krauss et al., PHARMACOLOGICAL EVIDENCE FOR THROMBOXANE RECEPTOR HETEROGENEITY - IMPLICATIONS FOR THE EYE, Journal of ocular pharmacology and therapeutics, 13(4), 1997, pp. 303-312

Authors: KRAUSS AHP PROTZMAN CE WOODWARD DF
Citation: Ahp. Krauss et al., INTRAOCULAR-PRESSURE REDUCTION VIA IMPROVED CONVENTIONAL OUTFLOW MAY INVOLVE A NOVEL PROSTANOID TP-RECEPTOR SUBTYPE, Investigative ophthalmology & visual science, 38(4), 1997, pp. 1131-1131

Authors: WOODWARD DF KRAUSS AHP GIBSON LL PROTZMAN CE BURK M GAC TS ROOF MB ABBASS F MARSHALL J SENIOR J
Citation: Df. Woodward et al., EVIDENCE FOR HUMAN THROMBOXANE RECEPTOR HETEROGENEITY USING NOVEL 9,11-CYCLIC CARBONATE DERIVATIVES OF PROSTAGLANDIN-F2-ALPHA, The FASEB journal, 10(3), 1996, pp. 852-852

Authors: KRAUSS AHP WOODWARD DF GIBSON LL PROTZMAN CE WILLIAMS LS BURK RM GAC TS ROOF MB ABBAS F MARSHALL K SENIOR J
Citation: Ahp. Krauss et al., EVIDENCE FOR HUMAN THROMBOXANE RECEPTOR HETEROGENEITY USING A NOVEL SERIES OF 9,11-CYCLIC CARBONATE DERIVATIVES OF PROSTAGLANDIN-F2-ALPHA, British Journal of Pharmacology, 117(6), 1996, pp. 1171-1180

Authors: KRAUSS AHP WOODWARD DF CHEN J GIBSON LL LAI RK PROTZMAN CE SHAN T WILLIAMS LS GAC TS BURK RM
Citation: Ahp. Krauss et al., AGN-191976 - A NOVEL THROMBOXANE-A(2)-MEMETIC WITH OCULAR HYPOTENSIVEPROPERTIES, Journal of ocular pharmacology and therapeutics, 11(3), 1995, pp. 203-212

Authors: FAIRBAIRN CE PROTZMAN CE KRAUSS AHP WOODWARD DF
Citation: Ce. Fairbairn et al., RADIOLIGAND BINDING ANALYSIS OF RECEPTOR SUBTYPES IN 2 FP RECEPTOR PREPARATIONS WHICH EXHIBIT DIFFERENT FUNCTIONAL POTENCY RANK ORDERS, The FASEB journal, 9(6), 1995, pp. 1453-1453

Authors: PROTZMAN CE FAIRBAIRN CE KRAUSS AHP WOODWARD DF
Citation: Ce. Protzman et al., RADIOLIGAND BINDING ANALYSIS OF RECEPTOR SUBTYPES IN 2 FP RECEPTOR PREPARATIONS WHICH EXHIBIT DIFFERENT FUNCTIONAL POTENCY RANK ORDERS, The FASEB journal, 9(3), 1995, pp. 112-112

Authors: WOODWARD DF FAIRBAIRN CE KRAUSS AHP LAWRENCE RA PROTZMAN CE
Citation: Df. Woodward et al., RADIOLIGAND BINDING ANALYSIS OF RECEPTOR SUBTYPES IN 2 FP RECEPTOR PREPARATIONS THAT EXHIBIT DIFFERENT FUNCTIONAL RANK ORDERS OF POTENCY INRESPONSE TO PROSTAGLANDINS, The Journal of pharmacology and experimental therapeutics, 273(1), 1995, pp. 285-291

Authors: BURK RM GAC TS GARST ME GIBSON LL KRAUSS AH PROTZMAN CE WOODWARD DF
Citation: Rm. Burk et al., SYNTHESIS OF A NOVEL SERIES OF 3-OXO-2,4-DIOXOBICYCLO[3.2.1]OCTANES -ADDITIONAL EVIDENCE FOR 2 THROMBOXANE RECEPTOR SUBTYPES, Bioorganic & medicinal chemistry letters, 4(17), 1994, pp. 2103-2106

Authors: CHENGBENNETT A CHAN MF CHEN G GAC T GARST ME GLUCHOWSKI C KAPLAN LJ PROTZMAN CE ROOF MB SACHS G WHEELER LA WILLIAMS LS WOODWARD DF
Citation: A. Chengbennett et al., STUDIES ON A NOVEL SERIES OF ACYL ESTER PRODRUGS OF PROSTAGLANDIN-F2-ALPHA, British journal of ophthalmology, 78(7), 1994, pp. 560-567

Authors: WOODWARD DF PROTZMAN CE KRAUSS AHP WILLIAMS LS
Citation: Df. Woodward et al., IDENTIFICATION OF 19(R)-OH PROSTAGLANDIN-E(2) AS A SELECTIVE PROSTANOID EP(2)-RECEPTOR AGONIST, Prostaglandins, 46(4), 1993, pp. 371-383

Authors: WILLIAMS LS NIEVES AL HAWLEY SB PROTZMAN CE SPADA CS WOODWARD DF
Citation: Ls. Williams et al., FURTHER-STUDIES ON THE OCULAR PHARMACOLOGY OF PROSTAGLANDIN-D2, Investigative ophthalmology & visual science, 33(4), 1992, pp. 1115-1115
Risultati: 1-14 |